Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	171,832	175,818	159,100	-	-	-
Market Cap Growth	18.76%	10.51%	-	-	-	-
Enterprise Value	168,685	173,015	157,079	-	-	-
Last Close Price	1642.50	1680.60	1512.33	-	-	-
PE Ratio	48.27	47.31	51.64	-	-	-
Forward PE	38.77	41.55	43.46	-	-	-
PS Ratio	14.46	14.65	15.65	-	-	-
PB Ratio	9.48	9.70	10.42	-	-	-
P/TBV Ratio	9.49	9.71	10.42	-	-	-
P/FCF Ratio	-	131.85	88.50	-	-	-
P/OCF Ratio	-	71.90	59.93	-	-	-
PEG Ratio	1.76	1.66	1.43	-	-	-
EV/Sales Ratio	14.20	14.42	15.45	-	-	-
EV/EBITDA Ratio	35.05	33.74	35.82	-	-	-
EV/EBIT Ratio	39.57	37.60	40.62	-	-	-
EV/FCF Ratio	-	129.75	87.37	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.09
Debt / EBITDA Ratio	0.01	0.01	0.02	0.09	0.22	0.27
Debt / FCF Ratio	-	0.02	0.05	0.31	1.19	-
Asset Turnover	-	0.64	0.63	0.60	0.57	0.58
Inventory Turnover	-	1.93	1.66	0.94	0.99	0.88
Quick Ratio	-	4.77	4.58	2.43	2.71	3.92
Current Ratio	-	6.17	6.31	3.79	4.08	5.74
Return on Equity (ROE)	-	22.26%	21.88%	20.06%	16.64%	26.55%
Return on Assets (ROA)	-	15.40%	15.04%	13.26%	11.47%	17.80%
Return on Capital (ROIC)	15.94%	17.16%	16.91%	15.07%	12.70%	19.78%
Return on Capital Employed (ROCE)	-	24.90%	24.80%	22.70%	19.80%	28.10%
Earnings Yield	2.07%	2.11%	1.94%	-	-	-
FCF Yield	-	0.76%	1.13%	-	-	-
Dividend Yield	0.65%	0.64%	0.58%	-	-	-
Payout Ratio	-	24.63%	23.19%	22.31%	40.31%	2.43%
Total Shareholder Return	0.60%	0.64%	0.58%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.